Biogen (BIIB) News Today → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free BIIB Stock Alerts $194.38 +3.86 (+2.03%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB)markets.businessinsider.com - April 19 at 12:46 PMPfizer On The New Lows List. Big Dividend Fails To Attract Buyers.forbes.com - April 19 at 12:46 PMOppenheimer Cuts Biogen (NASDAQ:BIIB) Price Target to $270.00marketbeat.com - April 19 at 11:16 AMWedbush Equities Analysts Decrease Earnings Estimates for Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 19 at 8:17 AMToday's Biggest Losersbaystreet.ca - April 19 at 7:46 AMMackenzie Financial Corp Purchases 13,796 Shares of Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 19 at 5:46 AMWedbush Lowers Biogen (NASDAQ:BIIB) Price Target to $213.00americanbankingnews.com - April 19 at 4:04 AMBiogen (NASDAQ:BIIB) Price Target Cut to $214.00americanbankingnews.com - April 19 at 3:08 AMQ3 2024 Earnings Forecast for Biogen Inc. Issued By Wedbush (NASDAQ:BIIB)americanbankingnews.com - April 19 at 2:31 AMBiogen Unusual Options Activity For April 18benzinga.com - April 18 at 3:55 PMUBS Group Lowers Biogen (NASDAQ:BIIB) Price Target to $214.00marketbeat.com - April 18 at 8:23 AMEquities Analysts Offer Predictions for Biogen Inc.'s Q3 2024 Earnings (NASDAQ:BIIB)marketbeat.com - April 18 at 6:16 AMBiogen (NASDAQ:BIIB) Reaches New 12-Month Low at $195.06americanbankingnews.com - April 18 at 4:52 AMWedbush Cuts Biogen (NASDAQ:BIIB) Price Target to $213.00marketbeat.com - April 17 at 3:44 PMBiogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growthfinance.yahoo.com - April 17 at 1:35 PMZurcher Kantonalbank Zurich Cantonalbank Reduces Stock Holdings in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 17 at 9:41 AMBiogen (BIIB) to Release Quarterly Earnings on Wednesdayamericanbankingnews.com - April 17 at 2:52 AMBiogen’s Alzheimer's drug to cost $3.5B for Medicare in 2025: reportmsn.com - April 16 at 8:29 PMBiogen Inc. (BIIB) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - April 16 at 3:28 PMLouisiana State Employees Retirement System Makes New Investment in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 14 at 10:55 AMBank of America Cuts Biogen (NASDAQ:BIIB) Price Target to $260.00americanbankingnews.com - April 14 at 4:38 AMBiogen Inc. (NASDAQ:BIIB) Sees Large Increase in Short Interestamericanbankingnews.com - April 13 at 6:26 AMJPMorgan Chase & Co. Lowers Biogen (NASDAQ:BIIB) Price Target to $240.00americanbankingnews.com - April 13 at 5:40 AMBiogen Inc. (NASDAQ:BIIB) to Post Q1 2024 Earnings of $3.31 Per Share, Leerink Partnrs Forecastsamericanbankingnews.com - April 13 at 1:32 AMBiogen Is Suffering From Doubts About the Futurefinance.yahoo.com - April 12 at 11:02 AMBank of America Trims Biogen (NASDAQ:BIIB) Target Price to $260.00marketbeat.com - April 12 at 8:27 AMQ1 2024 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Lifted by Analystmarketbeat.com - April 12 at 6:09 AMBiogen (NASDAQ:BIIB) Sets New 12-Month Low at $201.82americanbankingnews.com - April 12 at 4:30 AMQ3 2024 Earnings Estimate for Biogen Inc. Issued By Leerink Partnrs (NASDAQ:BIIB)americanbankingnews.com - April 12 at 1:36 AMJPMorgan Chase & Co. Trims Biogen (NASDAQ:BIIB) Target Price to $240.00marketbeat.com - April 11 at 9:17 AMQ3 2024 EPS Estimates for Biogen Inc. Cut by Analyst (NASDAQ:BIIB)marketbeat.com - April 11 at 7:11 AMReviewing Biogen (NASDAQ:BIIB) and BioAtla (NASDAQ:BCAB)americanbankingnews.com - April 10 at 1:42 AMBiogen: Doubts About The Futuregurufocus.com - April 7 at 12:03 PMNew York State Teachers Retirement System Cuts Stock Position in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 7 at 8:47 AMInternational Assets Investment Management LLC Acquires 474,992 Shares of Biogen Inc. (NASDAQ:BIIB)marketbeat.com - April 6 at 7:17 AMBiogen Inc. (NASDAQ:BIIB) Holdings Boosted by China Universal Asset Management Co. Ltd.marketbeat.com - April 4 at 6:45 PMBiogen (NASDAQ:BIIB) Given New $215.00 Price Target at Barclaysmarketbeat.com - April 4 at 10:16 AMQ4 2025 EPS Estimates for Biogen Inc. Reduced by Analyst (NASDAQ:BIIB)marketbeat.com - April 4 at 9:44 AMLooking Into Biogen's Recent Short Interestbenzinga.com - April 4 at 7:57 AMBiogen Inc. (NASDAQ:BIIB) Insider Sells $19,817.37 in Stockinsidertrades.com - April 4 at 7:09 AMBiogen Inc. (NASDAQ:BIIB) Insider Priya Singhal Sells 93 Sharesmarketbeat.com - April 3 at 9:45 PMQ3 2025 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Decreased by Zacks Researchmarketbeat.com - April 3 at 6:31 AMBiogen (NASDAQ:BIIB) Hits New 12-Month Low at $208.75marketbeat.com - April 2 at 12:50 PMBuy Rating on Biogen: Focused on Leqembi’s IV Dosing Amidst SQ Formulation Delaymarkets.businessinsider.com - April 1 at 6:21 PMHold Rating on Biogen Amidst Leqembi’s Regulatory Challenges and Competitive Pressuresmarkets.businessinsider.com - April 1 at 1:20 PMAnalysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT) and Biogen (BIIB)markets.businessinsider.com - April 1 at 1:20 PMBiogen's Leqembi filing setback 'negative for sentiment'uk.investing.com - April 1 at 8:19 AMEisai Submits Leqembi SBLA For IV Maintenance Dosing In Early Alzheimer's Diseasemarkets.businessinsider.com - April 1 at 1:15 AMEisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDAfinance.yahoo.com - March 31 at 8:15 PMState of Alaska Department of Revenue Has $9.98 Million Holdings in Biogen Inc. (NASDAQ:BIIB)marketbeat.com - March 31 at 5:53 AM Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. BIIB Media Mentions By Week BIIB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.190.51▲Average Medical News Sentiment BIIB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3416▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: American Electric Power News Today Neurocrine Biosciences News Today Repligen News Today Pinnacle West Capital News Today CRISPR Therapeutics News Today Portland General Electric News Today Denali Therapeutics News Today Gilead Sciences News Today argenx News Today BioNTech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm PressThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.